- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Needle-Free Drug Injection Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Needle-Free Drug Injection Systems size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Needle-Free Drug Injection Systems market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Needle-Free Drug Injection Systems market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Jet-Based Needle-Free Injectors
Spring-Based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Vibration-Based Needle-Free Injectors
Market segment by Application can be divided into
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology companies
Other End Users
The key market players for global Needle-Free Drug Injection Systems market are listed below:
Antares Pharma, Inc. (US)
Endo International plc (US)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (US)
Valeritas, Inc. (US)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Needle-Free Drug Injection Systems product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Needle-Free Drug Injection Systems, with price, sales, revenue and global market share of Needle-Free Drug Injection Systems from 2019 to 2021.
Chapter 3, the Needle-Free Drug Injection Systems competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Needle-Free Drug Injection Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Needle-Free Drug Injection Systems market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Needle-Free Drug Injection Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Needle-Free Drug Injection Systems Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Needle-Free Drug Injection Systems Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Jet-Based Needle-Free Injectors
1.2.3 Spring-Based Needle-Free Injectors
1.2.4 Laser-Powered Needle-Free Injectors
1.2.5 Vibration-Based Needle-Free Injectors
1.3 Market Analysis by Application
1.3.1 Overview: Global Needle-Free Drug Injection Systems Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals and Clinics
1.3.3 Homecare Settings
1.3.4 Research Laboratories
1.3.5 Pharmaceutical and Biotechnology companies
1.3.6 Other End Users
1.4 Global Needle-Free Drug Injection Systems Market Size & Forecast
1.4.1 Global Needle-Free Drug Injection Systems Sales in Value (2016-2026))
1.4.2 Global Needle-Free Drug Injection Systems Sales in Volume (2016-2026)
1.4.3 Global Needle-Free Drug Injection Systems Price by Type (2016-2026) & (USD/Unit)
1.5 Global Needle-Free Drug Injection Systems Production Capacity Analysis
1.5.1 Global Needle-Free Drug Injection Systems Total Production Capacity (2016-2026)
1.5.2 Global Needle-Free Drug Injection Systems Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Needle-Free Drug Injection Systems Market Drivers
1.6.2 Needle-Free Drug Injection Systems Market Restraints
1.6.3 Needle-Free Drug Injection Systems Trends Analysis
2 Manufacturers Profiles
2.1 Antares Pharma, Inc. (US)
2.1.1 Antares Pharma, Inc. (US) Details
2.1.2 Antares Pharma, Inc. (US) Major Business
2.1.3 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product and Services
2.1.4 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Endo International plc (US)
2.2.1 Endo International plc (US) Details
2.2.2 Endo International plc (US) Major Business
2.2.3 Endo International plc (US) Needle-Free Drug Injection Systems Product and Services
2.2.4 Endo International plc (US) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 PharmaJet (U.S)
2.3.1 PharmaJet (U.S) Details
2.3.2 PharmaJet (U.S) Major Business
2.3.3 PharmaJet (U.S) Needle-Free Drug Injection Systems Product and Services
2.3.4 PharmaJet (U.S) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Bioject Medical Technologies Inc. (U.S)
2.4.1 Bioject Medical Technologies Inc. (U.S) Details
2.4.2 Bioject Medical Technologies Inc. (U.S) Major Business
2.4.3 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product and Services
2.4.4 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Medical International Technology, Inc. (U.S)
2.5.1 Medical International Technology, Inc. (U.S) Details
2.5.2 Medical International Technology, Inc. (U.S) Major Business
2.5.3 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product and Services
2.5.4 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 INJEX Pharma AG (Germany)
2.6.1 INJEX Pharma AG (Germany) Details
2.6.2 INJEX Pharma AG (Germany) Major Business
2.6.3 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product and Services
2.6.4 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 National Medical Products Inc. (US)
2.7.1 National Medical Products Inc. (US) Details
2.7.2 National Medical Products Inc. (US) Major Business
2.7.3 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product and Services
2.7.4 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Valeritas, Inc. (US)
2.8.1 Valeritas, Inc. (US) Details
2.8.2 Valeritas, Inc. (US) Major Business
2.8.3 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product and Services
2.8.4 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 European Pharma Group (Netherland)
2.9.1 European Pharma Group (Netherland) Details
2.9.2 European Pharma Group (Netherland) Major Business
2.9.3 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product and Services
2.9.4 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 PenJet Corporation (U.S)
2.10.1 PenJet Corporation (U.S) Details
2.10.2 PenJet Corporation (U.S) Major Business
2.10.3 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product and Services
2.10.4 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Crossject SA (France)
2.11.1 Crossject SA (France) Details
2.11.2 Crossject SA (France) Major Business
2.11.3 Crossject SA (France) Needle-Free Drug Injection Systems Product and Services
2.11.4 Crossject SA (France) Needle-Free Drug Injection Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Needle-Free Drug Injection Systems Sales by Manufacturer
3.1 Global Needle-Free Drug Injection Systems Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Needle-Free Drug Injection Systems Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Needle-Free Drug Injection Systems
3.4 Market Concentration Rate
3.4.1 Top 3 Needle-Free Drug Injection Systems Manufacturer Market Share
3.4.2 Top 6 Needle-Free Drug Injection Systems Manufacturer Market Share
3.5 Global Needle-Free Drug Injection Systems Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Needle-Free Drug Injection Systems Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Needle-Free Drug Injection Systems Market Size by Region
4.1.1 Global Needle-Free Drug Injection Systems Sales in Volume by Region (2016-2026)
4.1.2 Global Needle-Free Drug Injection Systems Revenue by Region (2016-2026)
4.2 North America Needle-Free Drug Injection Systems Revenue (2016-2026)
4.3 Europe Needle-Free Drug Injection Systems Revenue (2016-2026)
4.4 Asia-Pacific Needle-Free Drug Injection Systems Revenue (2016-2026)
4.5 South America Needle-Free Drug Injection Systems Revenue (2016-2026)
4.6 Middle East and Africa Needle-Free Drug Injection Systems Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Needle-Free Drug Injection Systems Sales in Volume by Type (2016-2026)
5.2 Global Needle-Free Drug Injection Systems Revenue by Type (2016-2026)
5.3 Global Needle-Free Drug Injection Systems Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Needle-Free Drug Injection Systems Sales in Volume by Application (2016-2026)
6.2 Global Needle-Free Drug Injection Systems Revenue by Application (2016-2026)
6.3 Global Needle-Free Drug Injection Systems Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Needle-Free Drug Injection Systems Sales by Type (2016-2026)
7.2 North America Needle-Free Drug Injection Systems Sales by Application (2016-2026)
7.3 North America Needle-Free Drug Injection Systems Market Size by Country
7.3.1 North America Needle-Free Drug Injection Systems Sales in Volume by Country (2016-2026)
7.3.2 North America Needle-Free Drug Injection Systems Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Needle-Free Drug Injection Systems Sales by Type (2016-2026)
8.2 Europe Needle-Free Drug Injection Systems Sales by Application (2016-2026)
8.3 Europe Needle-Free Drug Injection Systems Market Size by Country
8.3.1 Europe Needle-Free Drug Injection Systems Sales in Volume by Country (2016-2026)
8.3.2 Europe Needle-Free Drug Injection Systems Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Needle-Free Drug Injection Systems Sales by Type (2016-2026)
9.2 Asia-Pacific Needle-Free Drug Injection Systems Sales by Application (2016-2026)
9.3 Asia-Pacific Needle-Free Drug Injection Systems Market Size by Region
9.3.1 Asia-Pacific Needle-Free Drug Injection Systems Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Needle-Free Drug Injection Systems Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Needle-Free Drug Injection Systems Sales by Type (2016-2026)
10.2 South America Needle-Free Drug Injection Systems Sales by Application (2016-2026)
10.3 South America Needle-Free Drug Injection Systems Market Size by Country
10.3.1 South America Needle-Free Drug Injection Systems Sales in Volume by Country (2016-2026)
10.3.2 South America Needle-Free Drug Injection Systems Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Needle-Free Drug Injection Systems Sales by Type (2016-2026)
11.2 Middle East & Africa Needle-Free Drug Injection Systems Sales by Application (2016-2026)
11.3 Middle East & Africa Needle-Free Drug Injection Systems Market Size by Country
11.3.1 Middle East & Africa Needle-Free Drug Injection Systems Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Needle-Free Drug Injection Systems Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Needle-Free Drug Injection Systems Typical Distributors
12.3 Needle-Free Drug Injection Systems Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Needle-Free Drug Injection Systems Revenue by Type, (USD Million), 2021-2026
Table 2. Global Needle-Free Drug Injection Systems Revenue by Application, (USD Million), 2021-2026
Table 3. Antares Pharma, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 4. Antares Pharma, Inc. (US) Major Business
Table 5. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product and Services
Table 6. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Endo International plc (US) Basic Information, Manufacturing Base and Competitors
Table 8. Endo International plc (US) Major Business
Table 9. Endo International plc (US) Needle-Free Drug Injection Systems Product and Services
Table 10. Endo International plc (US) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. PharmaJet (U.S) Basic Information, Manufacturing Base and Competitors
Table 12. PharmaJet (U.S) Major Business
Table 13. PharmaJet (U.S) Needle-Free Drug Injection Systems Product and Services
Table 14. PharmaJet (U.S) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bioject Medical Technologies Inc. (U.S) Basic Information, Manufacturing Base and Competitors
Table 16. Bioject Medical Technologies Inc. (U.S) Major Business
Table 17. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product and Services
Table 18. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Medical International Technology, Inc. (U.S) Basic Information, Manufacturing Base and Competitors
Table 20. Medical International Technology, Inc. (U.S) Major Business
Table 21. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product and Services
Table 22. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. INJEX Pharma AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 24. INJEX Pharma AG (Germany) Major Business
Table 25. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product and Services
Table 26. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. National Medical Products Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 28. National Medical Products Inc. (US) Major Business
Table 29. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product and Services
Table 30. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Valeritas, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 32. Valeritas, Inc. (US) Major Business
Table 33. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product and Services
Table 34. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. European Pharma Group (Netherland) Basic Information, Manufacturing Base and Competitors
Table 36. European Pharma Group (Netherland) Major Business
Table 37. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product and Services
Table 38. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. PenJet Corporation (U.S) Basic Information, Manufacturing Base and Competitors
Table 40. PenJet Corporation (U.S) Major Business
Table 41. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product and Services
Table 42. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Crossject SA (France) Basic Information, Manufacturing Base and Competitors
Table 44. Crossject SA (France) Major Business
Table 45. Crossject SA (France) Needle-Free Drug Injection Systems Product and Services
Table 46. Crossject SA (France) Needle-Free Drug Injection Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Needle-Free Drug Injection Systems Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Needle-Free Drug Injection Systems Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Needle-Free Drug Injection Systems, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Needle-Free Drug Injection Systems Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Needle-Free Drug Injection Systems Production Site of Key Manufacturer
Table 52. Needle-Free Drug Injection Systems New Entrant and Capacity Expansion Plans
Table 53. Needle-Free Drug Injection Systems Mergers & Acquisitions in the Past Five Years
Table 54. Global Needle-Free Drug Injection Systems Sales by Region (2016-2021e) & (K Units)
Table 55. Global Needle-Free Drug Injection Systems Sales by Region (2021-2026) & (K Units)
Table 56. Global Needle-Free Drug Injection Systems Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Needle-Free Drug Injection Systems Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Needle-Free Drug Injection Systems Sales by Type (2016-2021e) & (K Units)
Table 59. Global Needle-Free Drug Injection Systems Sales by Type (2021-2026) & (K Units)
Table 60. Global Needle-Free Drug Injection Systems Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Needle-Free Drug Injection Systems Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Needle-Free Drug Injection Systems Price by Type (2016-2021e) & (USD/Unit)
Table 63. Global Needle-Free Drug Injection Systems Price by Type (2021-2026) & (USD/Unit)
Table 64. Global Needle-Free Drug Injection Systems Sales by Application (2016-2021e) & (K Units)
Table 65. Global Needle-Free Drug Injection Systems Sales by Application (2021-2026) & (K Units)
Table 66. Global Needle-Free Drug Injection Systems Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Needle-Free Drug Injection Systems Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Needle-Free Drug Injection Systems Price by Application (2016-2021e) & (USD/Unit)
Table 69. Global Needle-Free Drug Injection Systems Price by Application (2021-2026) & (USD/Unit)
Table 70. North America Needle-Free Drug Injection Systems Sales by Country (2016-2021e) & (K Units)
Table 71. North America Needle-Free Drug Injection Systems Sales by Country (2021-2026) & (K Units)
Table 72. North America Needle-Free Drug Injection Systems Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Needle-Free Drug Injection Systems Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Needle-Free Drug Injection Systems Sales by Type (2016-2021e) & (K Units)
Table 75. North America Needle-Free Drug Injection Systems Sales by Type (2021-2026) & (K Units)
Table 76. North America Needle-Free Drug Injection Systems Sales by Application (2016-2021e) & (K Units)
Table 77. North America Needle-Free Drug Injection Systems Sales by Application (2021-2026) & (K Units)
Table 78. Europe Needle-Free Drug Injection Systems Sales by Country (2016-2021e) & (K Units)
Table 79. Europe Needle-Free Drug Injection Systems Sales by Country (2021-2026) & (K Units)
Table 80. Europe Needle-Free Drug Injection Systems Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Needle-Free Drug Injection Systems Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Needle-Free Drug Injection Systems Sales by Type (2016-2021e) & (K Units)
Table 83. Europe Needle-Free Drug Injection Systems Sales by Type (2021-2026) & (K Units)
Table 84. Europe Needle-Free Drug Injection Systems Sales by Application (2016-2021e) & (K Units)
Table 85. Europe Needle-Free Drug Injection Systems Sales by Application (2021-2026) & (K Units)
Table 86. Asia-Pacific Needle-Free Drug Injection Systems Sales by Region (2016-2021e) & (K Units)
Table 87. Asia-Pacific Needle-Free Drug Injection Systems Sales by Region (2021-2026) & (K Units)
Table 88. Asia-Pacific Needle-Free Drug Injection Systems Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Needle-Free Drug Injection Systems Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Needle-Free Drug Injection Systems Sales by Type (2016-2021e) & (K Units)
Table 91. Asia-Pacific Needle-Free Drug Injection Systems Sales by Type (2021-2026) & (K Units)
Table 92. Asia-Pacific Needle-Free Drug Injection Systems Sales by Application (2016-2021e) & (K Units)
Table 93. Asia-Pacific Needle-Free Drug Injection Systems Sales by Application (2021-2026) & (K Units)
Table 94. South America Needle-Free Drug Injection Systems Sales by Country (2016-2021e) & (K Units)
Table 95. South America Needle-Free Drug Injection Systems Sales by Country (2021-2026) & (K Units)
Table 96. South America Needle-Free Drug Injection Systems Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Needle-Free Drug Injection Systems Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Needle-Free Drug Injection Systems Sales by Type (2016-2021e) & (K Units)
Table 99. South America Needle-Free Drug Injection Systems Sales by Type (2021-2026) & (K Units)
Table 100. South America Needle-Free Drug Injection Systems Sales by Application (2016-2021e) & (K Units)
Table 101. South America Needle-Free Drug Injection Systems Sales by Application (2021-2026) & (K Units)
Table 102. Middle East & Africa Needle-Free Drug Injection Systems Sales by Country (2016-2021e) & (K Units)
Table 103. Middle East & Africa Needle-Free Drug Injection Systems Sales by Country (2021-2026) & (K Units)
Table 104. Middle East & Africa Needle-Free Drug Injection Systems Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Needle-Free Drug Injection Systems Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Needle-Free Drug Injection Systems Sales by Type (2016-2021e) & (K Units)
Table 107. Middle East & Africa Needle-Free Drug Injection Systems Sales by Type (2021-2026) & (K Units)
Table 108. Middle East & Africa Needle-Free Drug Injection Systems Sales by Application (2016-2021e) & (K Units)
Table 109. Middle East & Africa Needle-Free Drug Injection Systems Sales by Application (2021-2026) & (K Units)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Needle-Free Drug Injection Systems Typical Distributors
Table 113. Needle-Free Drug Injection Systems Typical Customers
List of Figures
Figure 1. Needle-Free Drug Injection Systems Picture
Figure 2. Global Needle-Free Drug Injection Systems Sales Market Share by Type in 2020
Figure 3. Jet-Based Needle-Free Injectors
Figure 4. Spring-Based Needle-Free Injectors
Figure 5. Laser-Powered Needle-Free Injectors
Figure 6. Vibration-Based Needle-Free Injectors
Figure 7. Global Needle-Free Drug Injection Systems Sales Market Share by Application in 2020
Figure 8. Hospitals and Clinics
Figure 9. Homecare Settings
Figure 10. Research Laboratories
Figure 11. Pharmaceutical and Biotechnology companies
Figure 12. Other End Users
Figure 13. Global Needle-Free Drug Injection Systems Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Needle-Free Drug Injection Systems Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Needle-Free Drug Injection Systems Sales (2016-2026) & (K Units)
Figure 16. Global Needle-Free Drug Injection Systems Price by Type (2016-2026) & (USD/Unit)
Figure 17. Global Needle-Free Drug Injection Systems Production Capacity (2016-2026) & (K Units)
Figure 18. Global Needle-Free Drug Injection Systems Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Needle-Free Drug Injection Systems Market Drivers
Figure 20. Needle-Free Drug Injection Systems Market Restraints
Figure 21. Needle-Free Drug Injection Systems Market Trends
Figure 22. Global Needle-Free Drug Injection Systems Sales Market Share by Manufacturer in 2020
Figure 23. Global Needle-Free Drug Injection Systems Revenue Market Share by Manufacturer in 2020
Figure 24. Needle-Free Drug Injection Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Needle-Free Drug Injection Systems Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Needle-Free Drug Injection Systems Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Needle-Free Drug Injection Systems Sales Market Share by Region (2016-2026)
Figure 28. Global Needle-Free Drug Injection Systems Revenue Market Share by Region (2016-2026)
Figure 29. North America Needle-Free Drug Injection Systems Revenue (2016-2026) & (USD Million)
Figure 30. Europe Needle-Free Drug Injection Systems Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Needle-Free Drug Injection Systems Revenue (2016-2026) & (USD Million)
Figure 32. South America Needle-Free Drug Injection Systems Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Needle-Free Drug Injection Systems Revenue (2016-2026) & (USD Million)
Figure 34. Global Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2026)
Figure 35. Global Needle-Free Drug Injection Systems Revenue Market Share by Type (2016-2026)
Figure 36. Global Needle-Free Drug Injection Systems Price by Type (2016-2026) & (USD/Unit)
Figure 37. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2026)
Figure 38. Global Needle-Free Drug Injection Systems Revenue Market Share by Application (2016-2026)
Figure 39. Global Needle-Free Drug Injection Systems Price by Application (2016-2026) & (USD/Unit)
Figure 40. North America Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2026)
Figure 41. North America Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2026)
Figure 42. North America Needle-Free Drug Injection Systems Sales Market Share by Country (2016-2026)
Figure 43. North America Needle-Free Drug Injection Systems Revenue Market Share by Country (2016-2026)
Figure 44. United States Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2026)
Figure 48. Europe Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2026)
Figure 49. Europe Needle-Free Drug Injection Systems Sales Market Share by Country (2016-2026)
Figure 50. Europe Needle-Free Drug Injection Systems Revenue Market Share by Country (2016-2026)
Figure 51. Germany Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Needle-Free Drug Injection Systems Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Needle-Free Drug Injection Systems Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Needle-Free Drug Injection Systems Revenue Market Share by Region (2016-2026)
Figure 60. China Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2026)
Figure 67. South America Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2026)
Figure 68. South America Needle-Free Drug Injection Systems Sales Market Share by Country (2016-2026)
Figure 69. South America Needle-Free Drug Injection Systems Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Needle-Free Drug Injection Systems Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Needle-Free Drug Injection Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
